fda zepbound news - Search News

FDA, Zepbound and obstructive sleep apnea

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

People on MSN · 5h

FDA Approves Weight Loss Medication Zepbound to Treat Sleep Apnea

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat their obstructive sleep apnea.

Yahoo · 2d

FDA approves Zepbound for obstructive sleep apnea

17hon MSN

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Milwaukee Journal Sentinel4d

Zepbound is the first medication approved to treat patients with obstructive sleep apnea, said Sally Seymour, the FDA's director of the division of pulmonology, allergy and critical care. The ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA, Zepbound and obstructive sleep apnea

Trending now

Related topics